Dr. Terence Rhodes
Overview
Dr. Terence Rhodes is the Senior Medical Director for Oncology for the Desert Region at Intermountain Health. With a robust background in medical oncology, Dr. Rhodes is dedicated to advancing quality patient care.Dr. Rhodes earned his MD and PhD from West Virginia University School of Medicine and the National Cancer Institute, where he specialized in Immunology, Microbiology, and Cell Biology. He completed his residency in Internal Medicine at WVU/Charleston Area Medical Center and his fellowship in Hematology/Oncology at Duke University Medical Center.His extensive training laid the foundation for his expertise in immuno-oncology and precision medicine. He has previously served as the Director of Immuno-Oncology and the Associate Director of Medical Oncology for Intermountain Health.Dr. Rhodes is passionate about scientific research and patient care, striving to make medicine better and deliver excellent care to as many people as possible. His vision includes advocating for providers and caregivers, ensuring clinical excellence, and fostering a culture of continuous learning and improvement.
Dr. Rhodes is rated as an Experienced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Colorectal Cancer, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Bone Marrow Aspiration, and Endoscopy.
His clinical research consists of co-authoring 5 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5121 S Cottonwood St Bldg 1 Ste 610, Murray, UT 84107
4403 Harrison Blvd Ste 2855, Ogden, UT 84403
201 W Layton Pkwy Ste 2A, Layton, UT 84041
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Imed Physicians
Tawnya Bowles is an Oncologist in Murray, Utah. Dr. Bowles is rated as a Distinguished provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. Her top areas of expertise are Melanoma, Liposarcoma, Merkel Cell Carcinoma, Small Bowel Resection, and Reconstructive Urology Surgery. Dr. Bowles is currently accepting new patients.
Imed Physicians
John Hyngstrom is an Oncologist in Murray, Utah. Dr. Hyngstrom is rated as a Distinguished provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Liposarcoma, and Epithelioid Sarcoma. Dr. Hyngstrom is currently accepting new patients.
Utah Cancer Specialists
Gregory Litton is an Oncologist in Salt Lake City, Utah. Dr. Litton is rated as a Distinguished provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Non-Hodgkin Lymphoma, and Pleuropulmonary Blastoma. Dr. Litton is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Rhodes isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Colorectal CancerDr. Rhodes isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Rhodes isDistinguished. Learn about Familial Colorectal Cancer.
- Lung AdenocarcinomaDr. Rhodes isDistinguished. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Rhodes isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Rhodes isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- Chromophobe Renal Cell CarcinomaDr. Rhodes isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Rhodes isAdvanced. Learn about Clear Cell Sarcoma.
- EGFR Positive Lung CancerDr. Rhodes isAdvanced. Learn about EGFR Positive Lung Cancer.
- Familial Wilms Tumor 2Dr. Rhodes isAdvanced. Learn about Familial Wilms Tumor 2.
- Large-Cell Lung CarcinomaDr. Rhodes isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung CancerDr. Rhodes isAdvanced. Learn about Lung Cancer.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Rhodes isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Rhodes isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Rhodes isExperienced. Learn about Agranulocytosis.
- Alveolar Soft Part SarcomaDr. Rhodes isExperienced. Learn about Alveolar Soft Part Sarcoma.